Nanosonics Limited (ASX:NAN)
3.310
-0.070 (-2.07%)
Feb 26, 2026, 2:19 PM AEST
Nanosonics Revenue
Nanosonics had revenue of 102.23M AUD in the half year ending December 31, 2025, with 28.37% growth. This brings the company's revenue in the last twelve months to 207.26M, up 12.66% year-over-year. In the fiscal year ending June 30, 2025, Nanosonics had annual revenue of 198.63M with 16.83% growth.
Revenue (ttm)
207.26M
Revenue Growth
+12.66%
P/S Ratio
4.95
Revenue / Employee
440.99K
Employees
470
Market Cap
1.03B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 198.63M | 28.62M | 16.83% |
| Jun 30, 2024 | 170.01M | 4.02M | 2.42% |
| Jun 30, 2023 | 165.99M | 45.67M | 37.96% |
| Jun 30, 2022 | 120.32M | 17.24M | 16.73% |
| Jun 30, 2021 | 103.08M | 3.03M | 3.02% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 23.10B |
| Sigma Healthcare | 6.00B |
| Cochlear | 2.34B |
| Integral Diagnostics | 767.89M |
| Pro Medicus | 240.57M |
| Neuren Pharmaceuticals | 218.86M |
| PolyNovo | 139.49M |
| PYC Therapeutics | 20.56M |
Nanosonics News
- 1 day ago - Nanosonics Ltd (NNCSF) (H1 2026) Earnings Call Highlights: Strong Revenue Growth Amidst Margin ... - GuruFocus
- 1 day ago - Nanosonics Limited (NNCSF) Q2 2026 Earnings Call Transcript - Seeking Alpha
- 1 day ago - Half Year 2026 Nanosonics Ltd Earnings Call Transcript - GuruFocus
- 4 months ago - Nanosonics Limited (NNCSF) Shareholder/Analyst Call Transcript - Seeking Alpha
- 6 months ago - Nanosonics Limited 2025 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 6 months ago - Nanosonics Limited (NNCSF) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 10 months ago - Billion-dollar medical start-ups say Trump could force a US move - The Australian Financial Review
- 1 year ago - Nanosonics Limited 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha